Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study
International Journal of Colorectal Disease · 14.05.2026 · 41 (1)
DOI: 10.1007/s00384-026-05148-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 14.05.2026. Verfasst von Qianwen Tu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University,…. Hauptthemen laut MEDLINE: Crohn Disease, Digestive System Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Patients with refractory perianal Crohn’s disease (RpCD) often face rectal resection and permanent ostomy as a final resort. The Turnbull–Cutait (TC) pull-through procedure offers a potential sphincter-preserving alternative, yet evidence supporting its use in RpCD remains scarce. This study evaluated the therapeutic efficacy of the TC procedure in this setting.
Methods
A retrospective analysis was conducted on ten patients with RpCD who planned to undergo TC surgery at Zhongnan Hospital of Wuhan University and the Sixth Affiliated Hospital of Sun Yat-sen University from January 2020 to June 2025; ultimately, eight patients completed the surgery. The median follow-up duration was 14.5 months.
Results
In the per-protocol analysis ( n = 8), the incidence of postoperative complications during follow-up was 37.5%, including 1 case of anal fistula recurrence, 1 case of anal incontinence, and 1 case of rectovaginal fistula recurrence. Five patients achieved short-term technical success, yielding a short-term technical success rate of 62.5%. Their median gastrointestinal quality of life index (GIQLI) score was 138 points, indicating an overall high quality of life.
Conclusion
The TC procedure may serve as a salvage option to avoid permanent stoma in strictly selected patients with RpCD. Although short-term clinical improvement was observed in some patients, the relatively high complication rate and an uncertain long-term efficacy warrant cautious application and careful patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
- Department of General Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655, China.
- Department of General Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655, China. kjia@mail.sysu.edu.cn.
- Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. dingzhao@whu.edu.cn.
Zitieren
APA
Tu, Q., Hu, H., Zhang, M., Luo, K., Wan, S., Li, D., Li, Y., Ke, J., & Ding, Z. (2026). Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study. International Journal of Colorectal Disease, 41(1). https://doi.org/10.1007/s00384-026-05148-0
Vancouver
Tu Q, Hu H, Zhang M, Luo K, Wan S, Li D, et al. Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study. International Journal of Colorectal Disease. 2026;41(1). doi:10.1007/s00384-026-05148-0
BibTeX
@article{Tu2026,
author = {Tu, Qianwen and Hu, Huanxin and Zhang, Mengting and Luo, Kangcheng and Wan, Songlin and Li, Daojiang and Li, Yi and Ke, Jia and Ding, Zhao},
title = {Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study},
journal = {International Journal of Colorectal Disease},
year = {2026},
volume = {41},
number = {1},
doi = {10.1007/s00384-026-05148-0}
}
EUVIMED